Evidence map›Paper›PMID 26211746›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2016

Hdac3 Deficiency Increases Marrow Adiposity and Induces Lipid Storage and Glucocorticoid Metabolism in Osteochondroprogenitor Cells.

Meghan E McGee-Lawrence, Lomeli R Carpio, Ryan J Schulze, Jessica L Pierce, Mark A McNiven, Joshua N Farr, Sundeep Khosla, Merry Jo Oursler, Jennifer J Westendorf

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Hdac3-deficiency increases senescence-associated distention of satellite DNA and telomere-associated foci in osteoprogenitor cells.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. m6A demethylase FTO and osteoporosis: potential therapeutic interventions.Frontiers in cell and developmental biology · 2023
    Review
  16. Article
  17. The Glucocorticoid Receptor in Osterix-Expressing Cells Regulates Bone Mass, Bone Marrow Adipose Tissue, and Systemic Metabolism in Female Mice During Aging.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
  18. Bioenergetic Metabolism In Osteoblast Differentiation.Current osteoporosis reports · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Meghan E McGee-LawrenceDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Lomeli R CarpioDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Ryan J SchulzeDepartment of Medicine, Division of Gastroenterology and Endocrinology, Mayo Clinic, Rochester, MN, USA.
Jessica L PierceDepartment of Cellular Biology and Anatomy, Georgia Regents University, Augusta, GA, USA.
Mark A McNivenDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Joshua N FarrDepartment of Medicine, Division of Endocrinology, Mayo Clinic, Rochester, MN, USA.
Sundeep KhoslaDepartment of Medicine, Division of Endocrinology, Mayo Clinic, Rochester, MN, USA.
Merry Jo OurslerDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Jennifer J WestendorfDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · USAugusta University · USGeorgia Regents Medical Center · US

Funding

SEX STEROIDS, GROWTH FACTORS, &BONE CELL FUNCTIONP01AG004875 · NIA · MAYO CLINIC ROCHESTER · PI MONROE, DAVID G · 1985 to 2019
$30.8M
Obesity and Energy Metabolism CoreP30DK050456 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI CROW, SCOTT J · 1995 to 2015
$17.0M
Musculoskeletal Research Training ProgramT32AR056950 · NIAMS · MAYO CLINIC ROCHESTER · PI Jennifer J Westendorf · 2009 to 2026
$7.0M
Canonical and Noncanonical Wnt Signaling in Osteoclast FunctionsR01AR065402 · NIAMS · MAYO CLINIC ROCHESTER · PI OURSLER, MERRY JO, WESTENDORF, JENNIFER J · 2015 to 2019
$2.4M
Relationship between Hdac3 suppression and Wnt signaling in osteoblastsF32AR060140 · NIAMS · MAYO CLINIC ROCHESTER · PI MCGEE-LAWRENCE, MEGHAN E. · 2010 to 2011
$99k
NIAMS NIH HHS F32 AR060140NIAMS NIH HHS F32 AR60140NIAMS NIH HHS R01 AR065402NIAMS NIH HHS T32 AR056950NIA NIH HHS AG004875NIA NIH HHS P01 AG004875NIDDK NIH HHS P30 DK050456NIDDK NIH HHS P30DK050456-18
6 · The paper itself

Abstract

Bone loss and increased marrow adiposity are hallmarks of aging skeletons. Conditional deletion of histone deacetylase 3 (Hdac3) in murine osteochondroprogenitor cells causes osteopenia and increases marrow adiposity, even in young animals, but the origins of the increased adiposity are unclear. To explore this, bone marrow stromal cells (BMSCs) from Hdac3-depleted and control mice were cultured in osteogenic medium. Hdac3-deficient cultures accumulated lipid droplets in greater abundance than control cultures and expressed high levels of genes related to lipid storage (Fsp27/Cidec, Plin1) and glucocorticoid metabolism (Hsd11b1) despite normal levels of Pparγ2. Approximately 5% of the lipid containing cells in the wild-type cultures expressed the master osteoblast transcription factor Runx2, but this population was threefold greater in the Hdac3-depleted cultures. Adenoviral expression of Hdac3 restored normal gene expression, indicating that Hdac3 controls glucocorticoid activation and lipid storage within osteoblast lineage cells. HDAC3 expression was reduced in bone cells from postmenopausal as compared to young women, and in osteoblasts from aged as compared to younger mice. Moreover, phosphorylation of S424 in Hdac3, a posttranslational mark necessary for deacetylase activity, was suppressed in osseous cells from old mice. Thus, concurrent declines in transcription and phosphorylation combine to suppress Hdac3 activity in aging bone, and reduced Hdac3 activity in osteochondroprogenitor cells contributes to increased marrow adiposity associated with aging. © 2015 American Society for Bone and Mineral Research.

Indexed as

AdiposityAgingLipid Metabolism11-beta-Hydroxysteroid Dehydrogenase Type 1AnimalsBone Marrow CellsCarrier ProteinsFemaleGlucocorticoidsHistone Deacetylase 3Histone DeacetylasesHumansMiceMice, TransgenicPerilipin-1Phosphoproteins11-beta-Hydroxysteroid Dehydrogenase Type 1Carrier Proteinsfat-specific protein 27, mouseGlucocorticoidsHistone Deacetylase 3Histone DeacetylasesPerilipin-1PhosphoproteinsPLIN1 protein, humanPlin1 protein, mousePPAR gammaProteinsAGINGHSD11B1LIPID DROPLETSOSTEOPOROSISRUNX2

Identifiers

PMID26211746
PMCPMC4758691
OpenAlexW1541481571

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.